Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1973 Jul;133(3):585–591. doi: 10.1042/bj1330585

The mechanism of inhibition of rat liver tryptophan pyrrolase activity by 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol)

Abdulla A-B Badawy 1, Myrddin Evans 1
PMCID: PMC1177737  PMID: 4354741

Abstract

1. Allopurinol (4-hydroxypyrazolo[3,4-d]pyrimidine) selectively inhibits the apotryptophan pyrrolase activity in homogenates of rat liver in vitro and after intraperitoneal administration. The inhibition is abolished by an excess of haematin. The allopurinol metabolite alloxanthine has no effect on the pyrrolase activity in vitro or after administration. Allopurinol also inhibits the activation of the enzyme in vitro by ascorbate, ethanol plus NAD+, NADH, hypoxanthine or xanthine. It is suggested that these agents cause the conversion of a latent form of the pyrrolase into the apoenzyme, and that xanthine oxidase is not involved in this process. 2. The raised total pyrrolase activity observed after the administration of cortisol, cyclic AMP, tryptophan, salicylate or ethanol is lowered by allopurinol in vitro to the corresponding holoenzyme values. A similar effect is observed when allopurinol is administered shortly before cortisol or cyclic AMP. Pretreatment of rats with allopurinol completely prevents the enhancement of the pyrrolase activities by tryptophan, salicylate or ethanol. 3. It is suggested that allopurinol inhibits rat liver tryptophan pyrrolase activity in vitro and after administration by preventing the conjugation of the apoenzyme with its haem activator. The possible usefulness of combined allopurinol–tryptophan therapy of affective disorders is discussed.

Full text

PDF
585

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badawy A. A., Smith M. J. Changes in liver tryptophan and tryptophan pyrrolase activity after administration of salicylate and tryptophan to the rat. Biochem Pharmacol. 1972 Jan;21(1):97–101. doi: 10.1016/0006-2952(72)90254-7. [DOI] [PubMed] [Google Scholar]
  2. Badawy A. A., Smith M. J. The effects of salicylate on the activity of rat liver tryptophan pyrrolase in vitro and in vivo. Biochem J. 1971 Jun;123(2):171–174. doi: 10.1042/bj1230171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Becking G. C., Johnson W. J. The inhibition of tryptophan pyrrolase by allopurinol, an inhibitor of xanthine oxidase. Can J Biochem. 1967 Nov;45(11):1667–1672. doi: 10.1139/o67-197. [DOI] [PubMed] [Google Scholar]
  4. Cho-Chung Y. S., Pitot H. C. Feedback control of rat liver tryptophan pyrrolase. I. End product inhibition of trytophan pyrrolase activity. J Biol Chem. 1967 Mar 25;242(6):1192–1198. [PubMed] [Google Scholar]
  5. Chytil F. Activation of liver tryptophan oxygenase by adenosine 3',5'-phosphate and by other purine derivatives. J Biol Chem. 1968 Mar 10;243(5):893–899. [PubMed] [Google Scholar]
  6. Curzon G. Effects of adrenal hormones and stress on brain serotonin. Am J Clin Nutr. 1971 Jul;24(7):830–834. doi: 10.1093/ajcn/24.7.830. [DOI] [PubMed] [Google Scholar]
  7. Curzon G. Tryptophan pyrrolase--a biochemical factor in depressive illness? Br J Psychiatry. 1969 Dec;115(529):1367–1374. doi: 10.1192/bjp.115.529.1367. [DOI] [PubMed] [Google Scholar]
  8. Della Corte E., Stirpe F. The regulation of xanthine oxidase. Inhibition by reduced nicotinamide-adenine dinucleotide of rat liver xanthine oxidase type D and of chick liver xanthine dehydrogenase. Biochem J. 1970 Mar;117(1):97–100. doi: 10.1042/bj1170097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elion G. B. Enzymatic and metabolic studies with allopurinol. Ann Rheum Dis. 1966 Nov;25(6 Suppl):608–614. doi: 10.1136/ard.25.suppl_6.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. FEIGELSON P., GREENGARD O. A microsomal iron-porphyrin activator of rat liver tryptophan pyrrolase. J Biol Chem. 1961 Jan;236:153–157. [PubMed] [Google Scholar]
  11. Green A. R., Curzon G. Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol. Nature. 1968 Dec 14;220(5172):1095–1097. doi: 10.1038/2201095a0. [DOI] [PubMed] [Google Scholar]
  12. Knox W. E. The regulation of tryptophan pyrrolase activity by tryptophan. Adv Enzyme Regul. 1966;4:287–297. doi: 10.1016/0065-2571(66)90023-9. [DOI] [PubMed] [Google Scholar]
  13. Lapin I. P., Oxenkrug G. F. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet. 1969 Jan 18;1(7586):132–136. doi: 10.1016/s0140-6736(69)91140-4. [DOI] [PubMed] [Google Scholar]
  14. Moon R. J. Tryptophan oxygenase and tryptophan metabolism in endotoxin-poisoned and allopurinol-treated mice. Biochim Biophys Acta. 1971 Feb 23;230(2):342–348. doi: 10.1016/0304-4165(71)90221-2. [DOI] [PubMed] [Google Scholar]
  15. Sourkes T. L., Missala K., Madras B. K. Effect of yohimbine on tryptophan metabolism. J Pharmacol Exp Ther. 1969 Feb;165(2):289–293. [PubMed] [Google Scholar]
  16. Watts R. W., Watts J. E., Seegmiller J. E. Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine). J Lab Clin Med. 1965 Oct;66(4):688–697. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES